Convertible Senior Notes Agreement Sample Contracts
EX-10.1 2 a17-4715_1ex10d1.htm EX-10.1 Incyte Corporation February 17, 2017 The Holders set forth on the Signature page to this AgreementConvertible Senior Notes Agreement • May 5th, 2020
Re: 0.375% Convertible Senior Notes due 2018 (CUSIP No. 45337CAK8) of Incyte Corporation (“2018 Notes”) and 1.25% Convertible Senior Notes due 2020 (CUSIP No. 45337CAL6) of Incyte Corporation (“2020 Notes”)
Incyte CorporationConvertible Senior Notes Agreement • November 15th, 2013 • Baker Julian • Services-commercial physical & biological research
By entering into this letter agreement (this “Agreement”), each party signing this Agreement under the heading “HOLDER” on the signature page hereto (each a “Holder” and, collectively, the “Holders”) and Incyte Corporation, a Delaware corporation (the “Company”) irrevocably agree as follows:
Re: 4.75% Convertible Senior Notes due 2015 (CUSIP No. 45337C AH5) (the “2015 Senior Notes”)Convertible Senior Notes Agreement • November 14th, 2013 • Incyte Corp • Services-commercial physical & biological research
By entering into this letter agreement (this “Agreement”), each party signing this Agreement under the heading “HOLDER” on the signature page hereto (each a “Holder” and, collectively, the “Holders”) and Incyte Corporation, a Delaware corporation (the “Company”) irrevocably agree as follows:
LinkedIn CorporationConvertible Senior Notes Agreement • November 7th, 2014 • Linkedin Corp • Services-computer programming, data processing, etc.
LinkedIn Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions set forth in this agreement (this “Agreement”), to issue and sell to the Purchasers named in Schedule I hereto (the “Purchasers”) an aggregate of $1,150,000,000 principal amount of its 0.50% Convertible Senior Notes due 2019 (the “Firm Securities”), and at the option of Goldman, Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (the “Representatives”) on behalf of the Purchasers, up to an aggregate of $172,500,000 additional principal amount of its 0.50% Convertible Senior Notes due 2019 (the “Optional Securities”, and together with the Firm Securities, the “Securities”). The Securities will be convertible into cash, shares (the “Underlying Shares”) of Class A Common Stock of the Company, par value $0.0001 per share (the “Class A Common Stock”) or a combination of cash and Underlying Shares, at the Company’s election.
Re: 4.75% Convertible Senior Notes due 2015 (CUSIP No. 45337C AH5) (the “2015 Senior Notes”)Convertible Senior Notes Agreement • November 14th, 2013 • Incyte Corp • Services-commercial physical & biological research
By entering into this letter agreement (this “Agreement”), each party signing this Agreement under the heading “HOLDER” on the signature page hereto (each a “Holder” and, collectively, the “Holders”) and Incyte Corporation, a Delaware corporation (the “Company”) irrevocably agree as follows:
Incyte CorporationConvertible Senior Notes Agreement • November 15th, 2013 • Baker Julian • Services-commercial physical & biological research
By entering into this letter agreement (this “Agreement”), each party signing this Agreement under the heading “HOLDER” on the signature page hereto (each a “Holder” and, collectively, the “Holders”) and Incyte Corporation, a Delaware corporation (the “Company”) irrevocably agree as follows: